SMITH & NEPHEW PLC (SNNUF) Financials
SNNUF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 10.0 billion | 4.8 billion |
| 2023-06-30 | 9.8 billion | 4.6 billion |
| 2023-03-31 | ? | ? |
| 2022-12-31 | 10.0 billion | 4.7 billion |
SNNUF Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | 239.6 million | ? |
| 2023-06-30 | -55.6 million | ? |
| 2023-03-31 | ? | ? |
| 2022-12-31 | 80.7 million | ? |
SNNUF Net Income
| Date | Net Income |
|---|---|
| 2023-12-31 | 92.5 million |
| 2023-06-30 | 177.0 million |
| 2023-03-31 | 86.0 million |
| 2022-12-31 | 47.4 million |
SNNUF Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 301.6 million | - | 199.0 million |
| 2023-06-30 | 190.0 million | - | 193.0 million |
| 2023-03-31 | - | - | - |
| 2022-12-31 | 350.0 million | - | 196.0 million |
SNNUF Shares Outstanding
SNNUF Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 261.4 million | 175.8 million | - | - |
| 2023-06-30 | 171.9 million | 170.9 million | - | - |
| 2023-03-31 | 83.5 million | - | - | - |
| 2022-12-31 | 207.3 million | 176.1 million | - | - |
SNNUF Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 2.9 billion | 908.3 million |
| 2023-06-30 | 2.8 billion | 860.5 million |
| 2023-03-31 | - | - |
| 2022-12-31 | 2.7 billion | 789.9 million |
SNNUF
Price: $12.81
Dividend Yield: 0.03%
Forward Dividend Yield: 3.61%
Payout Ratio: 154.00%
Dividend Per Share: 0.46 USD
Earnings Per Share: 0.30 USD
P/E Ratio: 53.80
Exchange: PNK
Sector: Healthcare
Industry: Medical Devices
Market Capitalization: 10.7 billion
Average Dividend Frequency: 2
Years Paying Dividends: 15
DGR3: 7.83%
DGR5: 6.09%
DGR10: 5.49%